Cresco Labs (OTCMKTS:CRLBF – Get Free Report) is projected to announce its results before the market opens on Friday, November 6th. Analysts expect the company to post earnings of ($0.02) per share and revenue of $173.66 million for the quarter.
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.06. The business had revenue of $173.34 million for the quarter, compared to analyst estimates of $166.20 million. Cresco Labs had a negative net margin of 15.50% and a negative return on equity of 7.53%. On average, analysts expect Cresco Labs to post ($0.04) EPS for the current fiscal year and ($0.02) EPS for the next fiscal year.
Cresco Labs Stock Performance
Shares of CRLBF stock opened at $0.59 on Thursday. The company has a current ratio of 1.78, a quick ratio of 0.98 and a debt-to-equity ratio of 1.66. The firm has a fifty day moving average price of $0.69 and a 200 day moving average price of $0.85. The company has a market cap of $220.95 million, a P/E ratio of -1.98 and a beta of 1.60. Cresco Labs has a 12 month low of $0.55 and a 12 month high of $2.30.
Wall Street Analyst Weigh In
A number of analysts have issued reports on the company. Zacks Research raised Cresco Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 6th. Alliance Global Partners reiterated a “buy” rating on shares of Cresco Labs in a report on Thursday, August 6th. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Strong Buy”.
Read Our Latest Stock Report on CRLBF
About Cresco Labs
Cresco Labs Inc is a Chicago-based cannabis company that cultivates, manufactures and distributes cannabis products in the United States. Founded in 2013, the company operates as a multistate cannabis operator, serving regulated markets through a combination of wholesale operations and retail dispensaries.
The company’s product portfolio includes flower, pre-rolls, vape products, concentrates, edibles and other cannabis-related goods. Its principal brands have included Cresco, High Supply, Good News, Wonder Wellness, FloraCal Farms and Mindy’s Edibles.
See Also
- Five stocks we like better than Cresco Labs
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.
